Gossamer Bio Inc (NASDAQ: GOSS) kicked off on Friday, down -3.88% from the previous trading day, before settling in for the closing price of $0.77. Over the past 52 weeks, GOSS has traded in a range of $0.50-$1.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 76.28%. With a float of $173.94 million, this company’s outstanding shares have now reached $225.41 million.
Let’s determine the extent of company efficiency that accounts for 135 employees. In terms of profitability, gross margin is 97.34%, operating margin of -56.03%, and the pretax margin is -60.96%.
Gossamer Bio Inc (GOSS) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Gossamer Bio Inc is 17.37%, while institutional ownership is 62.87%. The most recent insider transaction that took place on Jun 24 ’24, was worth 1,260. In this transaction Chief Medical Officer of this company sold 1,908 shares at a rate of $0.66, taking the stock ownership to the 196,891 shares. Before that another transaction happened on Jun 21 ’24, when Company’s President & CEO bought 372,000 for $0.67, making the entire transaction worth $250,282. This insider now owns 5,408,073 shares in total.
Gossamer Bio Inc (GOSS) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.21 earnings per share (EPS), higher than consensus estimate (set at -0.21) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 76.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.20% during the next five years compared to 11.99% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
Take a look at Gossamer Bio Inc’s (GOSS) current performance indicators. Last quarter, stock had a quick ratio of 6.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.69 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
Looking closely at Gossamer Bio Inc (NASDAQ: GOSS), its last 5-days average volume was 1.37 million, which is a drop from its year-to-date volume of 1.43 million. As of the previous 9 days, the stock’s Stochastic %D was 27.37%. Additionally, its Average True Range was 0.06.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 0.00%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 28.94% in the past 14 days, which was lower than the 64.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9325, while its 200-day Moving Average is $0.9385. However, in the short run, Gossamer Bio Inc’s stock first resistance to watch stands at $0.7667. Second resistance stands at $0.7933. The third major resistance level sits at $0.8066. If the price goes on to break the first support level at $0.7268, it is likely to go to the next support level at $0.7135. Now, if the price goes above the second support level, the third support stands at $0.6869.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
The company with the Market Capitalisation of 161.20 million has total of 226,604K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -179,820 K annual income. Company’s last quarter sales were recorded 9,480 K and last quarter income was -30,800 K.
